In a 31‑year‑old woman on propranolol who experiences brief episodes of tachycardia 170–180 bpm with shortness of breath and oxygen saturation 89–90 % at rest (including while lying down), similar episodes occurred during a prior pregnancy and were previously attributed to anxiety; what is the likely etiology and what urgent cardiac evaluation and management steps are recommended?

Urgent Cardiac Evaluation Required: Likely Supraventricular Tachycardia with Inadequate Beta-Blockade

This patient requires immediate cardiology referral and comprehensive cardiac workup—the combination of paroxysmal tachycardia to 170-180 bpm with transient hypoxemia (89-90%) and recurrence despite propranolol strongly suggests supraventricular tachycardia (SVT), most likely AVNRT or AVRT, that is inadequately controlled and potentially life-threatening.

Immediate Diagnostic Steps

Obtain a 12-lead ECG during an episode if possible, or at minimum a baseline ECG now. The key diagnostic features to identify:

• P-wave morphology and relationship to QRS complexes
• QRS width (narrow vs wide)
• Evidence of pre-excitation (delta waves suggesting WPW syndrome)
• Any signs of structural heart disease

Order the following labs urgently:

• Complete metabolic panel (electrolytes, particularly potassium and magnesium)
• Complete blood count (rule out anemia)
• Thyroid function tests (TSH, free T4)
• Troponin if any chest pain present

Arrange continuous cardiac monitoring with either a 24-48 hour Holter monitor or 30-day event monitor to capture episodes, as brief paroxysmal events may be missed on standard monitoring 1.

Most Likely Etiology

The clinical picture—brief episodes of regular tachycardia 170-180 bpm that spontaneously terminate and return to normal sinus rhythm in the 80s, occurring with activity or at rest, in a young woman with prior pregnancy-related episodes—is classic for paroxysmal supraventricular tachycardia (PSVT), most commonly AVNRT or AVRT 1, 2.

The transient hypoxemia (89-90%) is concerning and likely represents:

• Hemodynamic compromise from the rapid rate reducing cardiac output
• Potential pulmonary congestion from elevated filling pressures during tachycardia
• Anxiety-related hyperventilation (though less likely given the documented low O2 saturation)

Critical point: The fact that propranolol is not preventing these episodes suggests either inadequate dosing, wrong diagnosis (e.g., pre-excited AF where beta-blockers alone are insufficient), or a mechanism not responsive to beta-blockade alone 3.

Why This Is Not Just Anxiety

While anxiety was the prior attribution, several features argue against pure anxiety disorder:

• Documented objective tachycardia to 170-180 bpm (anxiety typically causes sinus tachycardia 100-130 bpm)
• Transient hypoxemia to 89-90% (not typical of anxiety)
• Sudden onset and termination (SVT characteristic, not anxiety)
• Failure to respond to beta-blocker therapy
• Recurrence during pregnancy (when SVT commonly manifests or worsens) 4, 2

Acute Management During Episodes

If the patient experiences an episode:

1. Vagal maneuvers immediately - Have patient perform Valsalva maneuver (bear down for 10-30 seconds against closed glottis, equivalent to 30-40 mmHg pressure) or apply ice-cold wet towel to face 1, 5

2. If vagal maneuvers fail and patient is stable: Call 911 or go to ED for adenosine administration

   • Adenosine 6 mg rapid IV bolus is first-line pharmacologic therapy
   • If ineffective, give 12 mg IV (can repeat once)
   • Adenosine terminates AVNRT in ~95% of cases 1, 5

3. If hemodynamically unstable (hypotensive, altered mental status, severe dyspnea): Immediate synchronized cardioversion 1

Optimization of Current Beta-Blocker Therapy

The current propranolol dose is likely inadequate. While you didn't specify the dose, typical effective dosing for SVT prophylaxis ranges from 80-320 mg daily, sometimes requiring up to 640 mg daily 3. However:

• Do not simply increase propranolol empirically without first establishing the diagnosis with ECG documentation
• If this is pre-excited atrial fibrillation (AF with WPW), beta-blockers can be dangerous as they may preferentially block the AV node and increase conduction down the accessory pathway, potentially causing ventricular fibrillation 4, 2

Definitive Management Path

Once SVT is confirmed, the patient should be offered catheter ablation as first-line definitive therapy 1, 6. The 2015 ACC/AHA/HRS guidelines give catheter ablation a Class I recommendation for symptomatic SVT, with success rates >95% and complication rates <1% 1.

If the patient declines ablation or it's not immediately available, ongoing pharmacologic management options include 1, 4, 1:

• Metoprolol (preferred beta-blocker, Class I recommendation for prophylaxis)
• Propranolol (Class IIa recommendation)
• Diltiazem or verapamil (Class IIa, but avoid if any concern for pre-excitation)
• Flecainide or propafenone (Class IIa, only if structurally normal heart confirmed)

Special Considerations Given Pregnancy History

The fact that similar episodes occurred during pregnancy 3 years ago is highly relevant. Pregnancy commonly unmasks or exacerbates SVT due to increased blood volume, cardiac output, and catecholamine levels 4, 2, 7.

If future pregnancy is planned:

• Catheter ablation should be strongly considered before conception to avoid medication exposure and complications during pregnancy 2
• If SVT occurs during future pregnancy: vagal maneuvers first, then adenosine (Class I), then IV metoprolol or propranolol (Class IIa), then cardioversion if needed 1, 4, 1

Red Flags Requiring Immediate ED Evaluation

Send the patient to the emergency department immediately if:

• Episode lasts >15-20 minutes despite vagal maneuvers
• Chest pain, severe dyspnea, or syncope occurs
• O2 saturation remains <90% for >2-3 minutes
• Patient appears hemodynamically unstable (hypotensive, altered mental status)

Common Pitfalls to Avoid

1. Do not dismiss as anxiety simply because prior providers did—objective tachycardia and hypoxemia require cardiac evaluation
2. Do not start or increase AV nodal blocking agents (beta-blockers, calcium channel blockers, digoxin) without first ruling out pre-excitation on ECG, as these can precipitate ventricular fibrillation in WPW with AF 4, 2
3. Do not delay cardiology referral—this patient has had symptoms for at least 3 years and deserves definitive diagnosis and treatment
4. Do not assume propranolol failure means no cardiac cause—it may indicate wrong drug, wrong dose, or specific SVT mechanism requiring different therapy

The bottom line: This patient needs urgent cardiology evaluation with ECG documentation of her tachycardia episodes, echocardiogram to assess for structural heart disease, and likely electrophysiology study with catheter ablation for definitive cure 1, 6.